Carole Ho - Insider Trading & Ownership

Entity
Individual
Location
C/O Denali Therapeutics Inc., 151 Oyster Point Blvd., 2 Nd Floor, South San Francisco, CA
Summary
The estimated net worth of Carole Ho is at least $674K dollars as of November 27, 2024. Carole Ho is the Director of Beam Therapeutics Inc. and owns shares of Beam Therapeutics Inc. (BEAM) stock worth about $564K. Carole Ho is the Chief Medical Officer of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $110K.
All Insider Reports
All Insider Reports

Ownership of Carole Ho

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
BEAM Beam Therapeutics Inc. Director $564K Jun 5, 2024
DNLI Denali Therapeutics Inc. Chief Medical Officer $110K -$959K -89.7% Nov 25, 2024
NGM NGM BIOPHARMACEUTICALS INC Director Apr 5, 2024

Insider Transactions Reported by Carole Ho:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.